Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Pharmacosmos"
Count: 47
Selected: 0
| NCT ID | Title |
|---|
| NCT05693909 | A Trial Testing SP-420 in Subjects With Transfusion-dependent β-thalassemia | ||
| NCT05545202 | A Randomized, Comparative, Double-blind Trial of Pentaisomaltose and Dimethyl Sulphoxide for Cryoprotection of Hematopoietic Stem Cells in Subjects With Multiple Myeloma or Malignant Lymphoma With a Need for Autologous Transplantation | ||
| NCT05179226 | Multi-center Trial of Ferric Derisomaltose in Children 0 to <18 Years of Age With Iron Deficiency Anemia | ||
| NCT02546154 | Time to Relapse of Iron Deficiency Anaemia After Standard Treatment With The Intravenous Iron (Monofer®) | ||
| NCT03466983 | A Trial Comparing the Incidence of Hypophosphatemia in Relation to Treatment With Iron Isomaltoside and Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia Due to Inflammatory Bowel Disease | ||
| NCT03188445 | Intravenous Iron Isomaltoside Versus Oral Iron Supplementation for Treatment of Iron Deficiency in Pregnancy. | ||
| NCT02940886 | Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA) | ||
| NCT02940860 | Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney Disease | ||
| NCT02962648 | An Extension Trial to Assess the Safety of Re-dosing of Iron Isomaltoside/Ferric Derisomaltose (Monofer®/Monoferric®) | ||
| NCT03238911 | Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose vs Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia | ||
| NCT03237065 | Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose or Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia | ||
| NCT02130063 | IDA-01 A Randomised, Open-Label, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) and Iron Sucrose | ||
| NCT01895231 | A Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Administered by Infusions to Iron-deficient Blood Donors | ||
| NCT03013439 | Dose-escalation Trial of the Safety, Pharmacokinetics, and Pharmacodynamics of Iron Isomaltoside (Monofer®) | ||
| NCT02301026 | A Non-interventional Study of Diafer in Subjects With CKD on Haemodialysis for Treatment of Iron Deficiency | ||
| NCT02172001 | A Randomized, Double-blind, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Against Placebo | ||
| NCT01900197 | Time to Relapse of Iron Deficiency Anemia After Standard Treatment With a New Intravenous Iron (Monofer®) | ||
| NCT01145638 | A Study of Intravenous Iron Isomaltoside 1000 (Monofer®) as Mono Therapy (Without Erythropoiesis Stimulating Agents) in Comparison With Oral Iron Sulfate in Subjects With Non-myeloid Malignancies Associated With Chemotherapy Induced Anaemia (CIA) | ||
| NCT01102413 | Iron Isomaltoside 1000 (Monofer®) in Non-Dialysis Dependent Chronic Kidney Disease and With Renal-Related Anaemia | ||
| NCT01222884 | A Randomized, Comparative, Open-label Study of IV Monofer® Administered as Maintenance Therapy by Single or Repeated Bolus Injections in Comparison With IV Iron Sucrose in Subjects With CKD-5D | ||
| NCT01895205 | Treatment of Women After Severe Postpartum Haemorrhage | ||
| NCT02484768 | IV Iron Treatment of Restless Legs Syndrome | ||
| NCT01895218 | Treatment of Women After Postpartum Haemorrhage | ||
| NCT01599702 | Iron Isomaltoside 1000 (Monofer®) Administered by a High Dosing Regimen in Subjects With Inflammatory Bowel Disease | ||
| NCT01563367 | A Prospective, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Administered by Infusions to Non-Anaemic Patients Undergoing Elective or Sub-Acute Coronary Artery Bypass Graft, Valve Replacement or a Combination Thereof | ||
| NCT01410435 | Safety and Efficacy Extension Study of Iron Isomaltoside 1000 (Monofer®) in Subjects With Inflammatory Bowel Disease | ||
| NCT01213992 | Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered by 500 mg IV Bolus Injection or 1000 mg Intravenous to Patients With CKD | ||
| NCT01213680 | Open-label PK Study of Iron Isomaltoside 1000 (Monofer) Administered by 500 mg IV Injection or 1000 mg IV Infusion to Patients With Inflammatory Bowel Disease | ||
| NCT01213979 | Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered by 500 mg IV Bolus Injection or 1000 mg Intravenous Infusion to Patients With Non-hematological Malignancies Associated With Chemotherapy Induced Anaemia (CIA) | ||
| NCT01280240 | Pharmacokinetic Study of Iron Isomaltoside 1000 Administered by 250 mg IV Bolus Injection or 500 mg Intravenous Infusion to Patients With Non-hematological Malignancies Associated With Chemotherapy Induced Anaemia | ||
| NCT01017614 | Iron Oligosaccharide in Inflammatory Bowel Disease Subjects With Iron Deficiency Anaemia | ||
| NCT01469078 | Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered as Single Bolus Injections in Subjects With Stage 5 Chronic Kidney Disease on Dialysis Therapy (CKD-5D) | ||
| NCT00537186 | A Study of Iron Oligosaccharide in CHF Patients | ||
| NCT00536666 | A Study of Iron Oligosaccharide in Chronic Kidney Disease Patients | ||
| NCT05714007 | The Effects of Ferric Derisomaltose on Postoperative Anemia in Spinal Deformity Surgery | ||
| NCT04913649 | Intravenous Iron to Treat Postoperative Anemia in Older Cardiac Surgery Patients | ||
| NCT05258825 | Preoperative Monoferric for Abdominal Surgery | ||
| NCT05467319 | Ferric Derisomaltose/Iron Isomaltoside and Outcomes in the Recovery of Gynecologic Oncology ERAS | ||
| NCT03662789 | Intravenous Iron Supplement for Iron Deficiency in Cardiac Transplant Recipients | ||
| NCT02038023 | Intravaneous Iron(1000 mg Low Molecular Weight Iron Dextran Over 60 Minutes) for Pregnant Women | ||
| NCT01927328 | Iron Replacement in Oesophagogastric Neoplasia | ||
| NCT05304442 | IV Iron Trial for Anemia Related to Uterine Bleeding in Female Patients Presenting to the Emergency Department | ||
| NCT04263571 | Hepcidin as a Predictor for the IVI Mediated Increase in Haemoglobin Levels | ||
| NCT02999217 | Intravenous Iron for Correction of Anaemia After Colorectal Surgery | ||
| NCT04945707 | Impact of Intravenous Iron Repletion On Mechanisms of Exercise InTolerance in HFpEF (IRONMET-HFpEF) | ||
| NCT02642562 | Intravenous Iron Treatment in Patients With Heart Failure and Iron Deficiency: IRONMAN | ||
| NCT04608539 | A Clinical Trial Assessing the Efficacy of Intravenous Iron for the Treatment of Anemia Following Cardiac Surgery |
